1. Home
  2. SOPH vs PROF Comparison

SOPH vs PROF Comparison

Compare SOPH & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$4.70

Market Cap

367.7M

Sector

Health Care

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.19

Market Cap

270.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
PROF
Founded
2011
N/A
Country
Switzerland
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
367.7M
270.7M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
SOPH
PROF
Price
$4.70
$6.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$7.00
$12.00
AVG Volume (30 Days)
100.3K
352.4K
Earning Date
03-03-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.89
EPS
N/A
1.41
Revenue
N/A
$16,098,000.00
Revenue This Year
$23.09
$115.41
Revenue Next Year
$19.57
$60.63
P/E Ratio
N/A
$4.47
Revenue Growth
N/A
50.73
52 Week Low
$2.58
$3.90
52 Week High
$5.70
$8.95

Technical Indicators

Market Signals
Indicator
SOPH
PROF
Relative Strength Index (RSI) 44.60 52.14
Support Level $4.54 $5.81
Resistance Level $4.86 $7.18
Average True Range (ATR) 0.27 0.47
MACD 0.01 0.11
Stochastic Oscillator 24.26 74.11

Price Performance

Historical Comparison
SOPH
PROF

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: